Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn on” Imaging and Synergistic Therapy
Small · 2023
DOI: 10.1002/smll.202206272 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Juanzu Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New …. Hauptthemen laut MEDLINE: Nanoparticles, Nanospheres, Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, Natural Science Foundation of Tianjin City.
Abstract (Originalsprache)
The redox homeostasis in tumors enhances their antioxidant defense ability, limiting reactive oxygen species mediated tumor therapy efficacy. The development of strategies for specific and continuous disruption of the redox homeostasis in tumor cells facilitates the improvement of the cancer therapeutic effect by promoting the apoptosis of tumor cells. Herein, a responsively biodegradable targeting multifunctional integrated nanosphere (HDMn‐QDs/PEG‐FA) is designed to enhance the anti‐tumor efficacy by triggering intratumoral cascade reactions to effectively disrupt intracellular redox homeostasis. Once HDMn‐QDs/PEG‐FA enters tumor cells, manganese dioxide (MnO 2 ) shell on the surface of nanosphere consumes glutathione (GSH) to produce Mn 2+ , enabling enhanced chemodynamic therapy (CDT) via a Fenton‐like reaction and T 1 ‐weighted magnetic resonance imaging. Meanwhile, the degradation of MnO 2 can also cause the fluorescence recovery of quantum dots conjugated on the surface of the shell, realizing “turn‐on” fluorescence imaging. In addition, the doxorubicin is released because of the cleavage of the embedded SS bond in the hybrid core framework by GSH. A superior synergistic therapeutic efficiency combined CDT and chemotherapy is shown by HDMn‐QDs/PEG‐FA in vivo. The tumor‐inhibition rate reaches to 94.8% and does not cause normal tissue damage due to the good targeting and tumor microenvironment‐specific response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medicinal Chemical Biology, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Matter, Research Center for Analytical Sciences, College of Ch…
- Cannano Jiayuan (Guangzhou) Science & Technology Co., Ltd, Guangzhou, 510700, P. R. China.
ORCID-Profile: Dai-Wen Pang, An-An Liu
Förderung
- Fundamental Research Funds for the Central Universities
- Natural Science Foundation of Tianjin City
Zitieren
APA
Liu, J., Zhu, H., Lin, L., Zhao, W., Zhu, X., Pang, D. W., & Liu, A. A. (2023). Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn on” Imaging and Synergistic Therapy. Small. https://doi.org/10.1002/smll.202206272
Vancouver
Liu J, Zhu H, Lin L, Zhao W, Zhu X, Pang DW, et al. Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn on” Imaging and Synergistic Therapy. Small. 2023. doi:10.1002/smll.202206272
BibTeX
@article{Liu2023,
author = {Liu, Juanzu and Zhu, Han and Lin, Leping and Zhao, Wei and Zhu, Xiaobo and Pang, Dai-Wen and Liu, An-An},
title = {Redox Imbalance Triggered Intratumoral Cascade Reaction for Tumor “turn on” Imaging and Synergistic Therapy},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202206272}
}
EUVIMED